Effects of travoprost eye drops on intraocular pressure and pulsatile ocular blood flow: a 180-day, randomized, double-masked comparison with latanoprost eye drops in patients with open-angle glaucoma (Q33738963)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effects of travoprost eye drops on intraocular pressure and pulsatile ocular blood flow: a 180-day, randomized, double-masked comparison with latanoprost eye drops in patients with open-angle glaucoma	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Effects of travoprost eye drops on intraocular pressure and pulsatile ocular blood flow: a 180-day, randomized, double-masked comparison with latanoprost eye drops in patients with open-angle glaucoma (English)

1 reference

Europe PubMed Central

29 July 2017

1 reference

based on heuristic

inferred from title

author name string

Nicola Cardascia

1

1 reference

Europe PubMed Central

29 July 2017

Michele Vetrugno

2

1 reference

Europe PubMed Central

29 July 2017

Tiziana Trabucco

3

1 reference

Europe PubMed Central

29 July 2017

Francesco Cantatore

4

1 reference

Europe PubMed Central

29 July 2017

Carlo Sborgia

5

1 reference

Europe PubMed Central

29 July 2017

publication date

1 July 2003

1 reference

Europe PubMed Central

29 July 2017

Current Therapeutic Research

1 reference

Europe PubMed Central

29 July 2017

64

1 reference

Europe PubMed Central

29 July 2017

7

1 reference

Europe PubMed Central

29 July 2017

389-400

1 reference

Europe PubMed Central

29 July 2017

Travoprost--a new prostaglandin analogue for the treatment of glaucoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Topical latanoprost and optic nerve head and retinal circulation in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Autoregulation of ocular blood flow during changes in intraocular pressure. Preliminary results.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Effect of different antiglaucomatous drugs on ocular perfusion pressures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Control of retinal and choroidal blood flow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Postural studies in pulsatile ocular blood flow: II. Chronic open angle glaucoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

The short-term effect of latanoprost on intraocular pressure and pulsatile ocular blood flow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Acute and chronic effects of brimonidine 0.2% on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: an open-label, uncontrolled, prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Effect of latanoprost on ocular hemodynamics and contrast sensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Potential neuroprotective therapy for glaucomatous optic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Prevent Blindness America visual field screening study. The Prevent Blindness America Glaucoma Advisory Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0011-393X%2803%2900112-7

7 January 2021

Ocular blood flow changes with increased vascular resistance external and internal to the eye

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Latanoprost 0.005% in POAG: effects on IOP and ocular blood flow

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood flow in the human eye

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S0011-393X(03)00112-7

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33738963&oldid=1957210897"